Simon Sharon Net Worth

Simon Sharon biography

Simon Sharon is Chief Technology Officer of the Company. Mr. Sharon is a seasoned medical device executive with over 30 years of industry experience. Prior to rejoining Microbot, Simon served as the Chief Technology Officer at MEDX Xelerator, an Israel-based medical device and digital health incubator with partners such as Boston Scientific Corporation and Intellectual Ventures. He was also the Chairman of the Scientific Board at XACT Robotics, a private Israeli company developing a novel platform robotic technology for needle steering in minimally invasive interventional procedures. Prior to this, Mr. Sharon held the position of Chief Operating Officer at Microbot Medical Ltd. before it became a publicly traded company. Prior to joining Microbot in 2013, Mr. Sharon was the Vice President of Research & Development with IceCure Medical, a TASE traded company developing a portfolio of cryogenic ablation systems. Prior to IceCure, he held roles of increasing responsibility at Rockwell Automation–Anorad Israel Ltd, a leading linear motor-based, precision positioning equipment manufacturer. Prior to Rockwell, Simon was the Research & Development Manager at Disc-O-Tech Medical Technologies Ltd., a private orthopedic venture that was acquired by Kyphon (currently part of Medtronic), and before this was the Research & Development Manager at CI Systems, a worldwide supplier of a wide range of electro-optical test and measurement equipment.

What's Simon Sharon's mailing address?

Simon's mailing address filed with the SEC is C/O MICROBOT MEDICAL INC., 288 GROVE STREET, SUITE 388, BRAINTREE, MA, 02184.

Insiders trading at Microbot Medical Inc

Over the last 8 years, insiders at Microbot Medical Inc have traded over $5,894,432 worth of Microbot Medical Inc stock and bought 10,000 units worth $11,000 . The most active insiders traders include Yoseph Bornstein, Investment Management Ltd A..., and Moshe Shoham. On average, Microbot Medical Inc executives and independent directors trade stock every 37 days with the average trade being worth of $46,188. The most recent stock trade was executed by Yoseph Bornstein on 19 October 2020, trading 4,881 units of MBOT stock currently worth $38,755.

What does Microbot Medical Inc do?

microbot medical was founded with the vision of pioneering micro invasive surgery, transforming one of the biggest trends in healthcare - minimally invasive surgery (estimated to be close to $20b by 2015); the company will provide transformational micro invasive technologies with the accuracy of robots and automated instruments to assist physicians in targeting the disease site with exquisite precision. microbot will solve one of the largest unmet needs in the medical field, where morbidity as a result of surgery is more frequently due to trauma involved in gaining access to the area to perform the intended procedure rather than from the procedure itself. through its unique platforms, microbot will reach multiple surgical spaces, capitalizing on the fact that minimally invasive techniques have been applied to most of the surgical specialties. microbot’s virob platform is an autonomous advancing micro robot (aamr), less then 1mm in diameter, which has the ability to advance (forward/bac

Microbot Medical Inc executives and stock owners

Microbot Medical Inc executives and other stock owners filed with the SEC include:

• Harel Gadot,
  Chairman of the Board, President, Chief Executive Officer
• Harel Gadot,
  Co-Founder, Pres, CEO & Chairman
• Dr. Eyal Morag M.D.,
  Chief Medical Officer
• David Ben Naim,
  Chief Financial Officer
• David Ben Naim CPA, M.B.A.,
  Chief Financial Officer
• Tal Wenderow,
  Independent Director
• Aileen Stockburger,
  Independent Director
• Martin Madden,
  Independent Director
• Prattipati Laxminarain,
  Independent Director
• Scott Burell,
  Independent Director
• Yoseph Bornstein,
  Independent Director
• Eyal Morag,
  Chief Medical Officer
• Simon Sharon,
  Chief Technology Officer
• Dr. Eric C. Leuthardt,
  Scientific Director & Member of Scientific Advisory Board
• Dr. Simon Sharon MBA, MSc,
  GM, CTO & Chairman of Scientific Advisory Board
• Prof. Moshe Shoham,
  Co-Founder, Scientific Director & Member of Scientific Advisory Board
• Yoav Zvi Waizer,
  Director
• Leon Lewkowicz,
  10% owner
• Capital Anstalt Alpha,
  10% owner
• Moshe Shoham,
  Director
• Yehezkel Himelfarb,
  COO and General Manager
• Investment Management Ltd A...,
  10% owner
• Rachel Vaknin,
  Chief Financial Officer
• Juan Diaz Cartelle,
  Chief Medical Officer